Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2014

01.08.2014 | Clinical Practice: Clinical Vignettes

Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones

verfasst von: Vikas Khullar, MD, Ankur Jain, MD, Maryam Sattari, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

ABSTRACT

Designer drugs represent an increasingly popular form of recreational substance abuse, especially amongst young adults. The two classes of designer drugs that have recently risen to prominence are the synthetic cannabinoids and synthetic cathinones. These substances are not detected by conventional drug screening methods and can often be associated with serious health consequences, including seizures, renal failure and death. Thus, clinicians should be familiar with the signs, symptoms, and toxicities associated with the use of these substances, and maintain a high level of suspicion for synthetic drugs as an alternative means of “getting high.” We present a case of a 20-year-old college student who presented to the emergency department with altered mental status and severe agitation who later admitted to using bath salts. The goal of this article is to raise awareness about these new designer drugs, their clinical presentation, and management of their intoxication.
Literatur
2.
Zurück zum Zitat Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):849–63.PubMedCrossRef Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):849–63.PubMedCrossRef
3.
Zurück zum Zitat Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49(10):910–41.PubMedCrossRef Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49(10):910–41.PubMedCrossRef
7.
Zurück zum Zitat Gershman JA, Fass AD. Synthetic cathinones ('bath salts'): legal and health care challenges. P T. 2012;37(10):571–95.PubMedCentralPubMed Gershman JA, Fass AD. Synthetic cathinones ('bath salts'): legal and health care challenges. P T. 2012;37(10):571–95.PubMedCentralPubMed
10.
Zurück zum Zitat Ross EA, Watson M, Goldberger B. "Bath salts" intoxication. N Engl J Med. 2011;365(10):967–8.PubMedCrossRef Ross EA, Watson M, Goldberger B. "Bath salts" intoxication. N Engl J Med. 2011;365(10):967–8.PubMedCrossRef
12.
Zurück zum Zitat Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother. 2012;46(3):436–41.PubMedCrossRef Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother. 2012;46(3):436–41.PubMedCrossRef
13.
14.
Zurück zum Zitat Mugele J, Nanagas KA, Tormoehlen LM. Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med. 2012;60(1):100–2.PubMedCrossRef Mugele J, Nanagas KA, Tormoehlen LM. Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med. 2012;60(1):100–2.PubMedCrossRef
15.
Zurück zum Zitat Caffery T, Musso M, Manausa R, Everett J, Perret J. Riding high on cloud 9. J La State Med Soc. 2012;164(4):186–9.PubMed Caffery T, Musso M, Manausa R, Everett J, Perret J. Riding high on cloud 9. J La State Med Soc. 2012;164(4):186–9.PubMed
17.
Zurück zum Zitat Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 2010;160(3):585–93.PubMedCentralPubMedCrossRef Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 2010;160(3):585–93.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.PubMedCrossRef Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.PubMedCrossRef
19.
Zurück zum Zitat Jiang W, Zhang Y, Xiao L, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005;115(11):3104–16.PubMedCentralPubMedCrossRef Jiang W, Zhang Y, Xiao L, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005;115(11):3104–16.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int. 2009;106(27):464–7.PubMedCentralPubMed Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int. 2009;106(27):464–7.PubMedCentralPubMed
21.
22.
Zurück zum Zitat Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & Experimental Toxicology. 2012;31(10):1006–11.CrossRef Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & Experimental Toxicology. 2012;31(10):1006–11.CrossRef
23.
Zurück zum Zitat Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.PubMedCentralPubMed Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.PubMedCentralPubMed
25.
Zurück zum Zitat Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157–62.PubMedCrossRef Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157–62.PubMedCrossRef
26.
Zurück zum Zitat Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7. Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7.
27.
Zurück zum Zitat Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26(6):462–5.PubMedCrossRef Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26(6):462–5.PubMedCrossRef
28.
Zurück zum Zitat Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. Netherlands. 2010;118:309–10.CrossRef Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. Netherlands. 2010;118:309–10.CrossRef
29.
Zurück zum Zitat Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use. Clin Schizophr Relat Psychoses. Mar 21 2013: 1–13. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use. Clin Schizophr Relat Psychoses. Mar 21 2013: 1–13.
30.
Zurück zum Zitat Acute kidney injury associated with synthetic cannabinoid use–multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):93–8. Acute kidney injury associated with synthetic cannabinoid use–multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):93–8.
31.
Zurück zum Zitat Kazory A, Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association. Clinical Kidney Journal. 2013;6(3):330–3.CrossRef Kazory A, Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association. Clinical Kidney Journal. 2013;6(3):330–3.CrossRef
32.
Zurück zum Zitat Daccarett M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol. Netherlands. 2007;119:235–6.CrossRef Daccarett M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol. Netherlands. 2007;119:235–6.CrossRef
33.
Zurück zum Zitat Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.PubMedCrossRef Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.PubMedCrossRef
34.
Zurück zum Zitat Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication–a case report of possible association. Med Sci Monit. 2000;6(2):386–9.PubMed Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication–a case report of possible association. Med Sci Monit. 2000;6(2):386–9.PubMed
35.
Zurück zum Zitat Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997;36(1):45–8.PubMedCrossRef Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997;36(1):45–8.PubMedCrossRef
36.
Zurück zum Zitat Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how 'safe' is it? Eur Neurol. 2000;44(1):42–4. Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how 'safe' is it? Eur Neurol. 2000;44(1):42–4.
37.
Zurück zum Zitat Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60(4):435–8.PubMedCrossRef Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60(4):435–8.PubMedCrossRef
38.
Zurück zum Zitat D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci. 2009;259(7):413–31.PubMedCentralPubMedCrossRef D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci. 2009;259(7):413–31.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694–701.PubMedCrossRef Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694–701.PubMedCrossRef
40.
Zurück zum Zitat Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010;200(1–3):141–7.PubMedCrossRef Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010;200(1–3):141–7.PubMedCrossRef
41.
Zurück zum Zitat Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med. 2012;79(4):258–64.PubMedCrossRef Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med. 2012;79(4):258–64.PubMedCrossRef
Metadaten
Titel
Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones
verfasst von
Vikas Khullar, MD
Ankur Jain, MD
Maryam Sattari, MD, MS
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2014
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2802-4

Weitere Artikel der Ausgabe 8/2014

Journal of General Internal Medicine 8/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.